Novel mouse models to investigate cdc6 in growth-control and cancer

Informations projet

MICHAELRUGAARDJENSEN

N° de convention de subvention: QLG1-CT-1999-51151

Projet clôturé

Date de début 1 Janvier 2000

Date de fin 31 Decembre 2001

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 131 012,00

Contribution de l’UE € 131 012,00

Coordonné par

ISTITUTO EUROPEO DI ONCOLOGIA SRL
Italy

Objectif

Establishment of novel mouse models, which either over express or are deficient for the E2F regulated gene cdc6 to investigate its role in cell cycle control, development and tumorigenesis.

Champ scientifique

• medical and health sciences › clinical medicine › oncology

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Appel à propositions

Data not available

Régime de financement

RGI - Research grants (individual fellowships)

Coordinateur

ISTITUTO EUROPEO DI ONCOLOGIA SRL

• Contribution de l’UE: Aucune donnée
• Adresse: Via Ripamonti 435 ; 20141 MILANO ; Italie
• Coût total: Aucune donnée